CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.576
EU - Europa 6.765
AS - Asia 6.077
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 128
OC - Oceania 58
Totale 25.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.346
SE - Svezia 2.164
SG - Singapore 1.900
CN - Cina 1.621
GB - Regno Unito 1.591
IT - Italia 1.115
HK - Hong Kong 832
BR - Brasile 582
VN - Vietnam 496
DE - Germania 472
FI - Finlandia 398
BD - Bangladesh 303
FR - Francia 222
RU - Federazione Russa 214
TR - Turchia 209
UA - Ucraina 194
KR - Corea 181
CA - Canada 119
IN - India 116
ID - Indonesia 89
BG - Bulgaria 85
AR - Argentina 78
NL - Olanda 65
MX - Messico 61
AU - Australia 55
IQ - Iraq 47
JP - Giappone 34
ZA - Sudafrica 32
EC - Ecuador 30
IE - Irlanda 29
MY - Malesia 29
EG - Egitto 27
PL - Polonia 26
VE - Venezuela 26
RO - Romania 25
AE - Emirati Arabi Uniti 24
ES - Italia 23
AT - Austria 22
BE - Belgio 22
PK - Pakistan 21
PH - Filippine 20
SA - Arabia Saudita 20
CO - Colombia 19
LT - Lituania 19
CL - Cile 17
UZ - Uzbekistan 17
DK - Danimarca 15
IR - Iran 15
MA - Marocco 14
TN - Tunisia 14
IL - Israele 13
JO - Giordania 13
TH - Thailandia 12
CZ - Repubblica Ceca 11
QA - Qatar 11
KE - Kenya 10
NP - Nepal 10
AZ - Azerbaigian 9
CH - Svizzera 9
DO - Repubblica Dominicana 8
HN - Honduras 8
PE - Perù 8
CR - Costa Rica 7
GR - Grecia 7
MK - Macedonia 6
PY - Paraguay 6
RS - Serbia 6
TW - Taiwan 6
UY - Uruguay 6
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
BF - Burkina Faso 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
KG - Kirghizistan 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
AL - Albania 3
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
JM - Giamaica 3
KZ - Kazakistan 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
NG - Nigeria 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
Totale 25.359
Salva come PNG Salva come JPEG
Città #
Stockholm 1.785
Singapore 1.286
Santa Clara 1.156
Ashburn 1.087
Southend 1.062
Fairfield 889
Hong Kong 807
San Jose 696
Chandler 659
Woodbridge 642
Hefei 599
Houston 452
Jacksonville 391
Seattle 350
Wilmington 335
Council Bluffs 332
Cambridge 321
Helsinki 313
Dearborn 297
Beijing 277
Ann Arbor 255
London 255
Nyköping 243
Los Angeles 194
Seoul 178
Cincinnati 172
Ho Chi Minh City 154
New York 152
Modena 132
Hanoi 120
The Dalles 116
Izmir 112
Milan 106
San Diego 104
Chicago 95
Princeton 92
Bremen 83
Sofia 82
Lauterbourg 80
Buffalo 75
Eugene 70
Jakarta 66
Moscow 65
Grafing 61
Des Moines 57
Boardman 55
Dallas 55
Shanghai 53
Munich 52
Rome 49
São Paulo 49
Orem 46
Columbus 45
Melbourne 42
Falls Church 41
Bologna 38
Reggio Emilia 37
Phoenix 35
Salt Lake City 34
Montreal 30
Frankfurt am Main 29
Nuremberg 29
Kent 28
Parma 27
Brooklyn 26
Haiphong 26
Tokyo 26
Dublin 25
Toronto 25
Amsterdam 22
Guangzhou 22
Atlanta 21
Da Nang 21
Naples 21
Elk Grove Village 20
Brussels 19
Denver 19
Nanjing 19
North Bergen 19
Redwood City 19
Johannesburg 18
Mexico City 18
Chennai 17
Mumbai 17
Warsaw 17
Baghdad 16
Miano 16
Ottawa 16
Rio de Janeiro 16
San Francisco 16
Tampa 16
Charlotte 15
Manchester 15
Timisoara 15
Fremont 14
Norwalk 14
Palermo 14
Poplar 14
Verona 14
Belo Horizonte 13
Totale 18.290
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.052
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 534
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 488
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 439
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 416
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 376
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 371
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 368
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 367
Management of bone disease in Gaucher disease type 1: clinical practice 365
Nutrition in adult patients with selected lysosomal storage diseases 361
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 356
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 353
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 346
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 339
Growth of human herpesvirus 6 in HepG2 cells 331
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 323
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 319
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 319
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 316
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 311
Cholesterol esterase activity of human intestinal mucosa 310
Review article: effect of bile salt pool composition on hepatic and biliary functions 308
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 300
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 297
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 295
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 294
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 290
Bile acid structure and regulation of biliary protein secretion and composition in man 276
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 276
Anatomia e fisiologia delle vie biliari 274
Global multi-stakeholder endorsement of the MAFLD definition 269
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 268
Nonalcoholic fatty liver disease induced by leuprorelin acetate 267
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 266
Fabry disease: raising awareness of the disease among physicians 264
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 263
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 259
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 257
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 256
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 254
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 253
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 250
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 248
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 246
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 240
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 240
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 240
Bile acid and hepatocyte death 229
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 229
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 227
Minimal disease activity in Gaucher disease: criteria for definition 227
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 223
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 223
Gaucher Disease in Bone: From Pathophysiology to Practice 219
Cholesterol Esterase Activity of human intestinal mucosa 218
Cholesterol esterase activity of human intestinal mucosa 217
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 210
Hyperferritinemia and diagnosis of type 1 Gaucher disease 207
Prevalence rates of gallstone disease in Italy: the Chianciano population study 201
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 199
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 199
Regulation of cholesterol absorption in humans 193
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 192
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 191
Patogenesi della colelitiasi 190
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 190
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 187
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 186
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 181
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 179
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 177
Nuove prospettive terapeutiche con acidi biliari. 175
Inquadramento delle sindromi colestatiche. 174
Regulation of bile acid synthesis in humans 172
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 172
Cholesterol esterase activity in the small bowel of humans 164
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 163
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 162
LA SECREZIONE LIPIDICA BILIARE 155
Malattie delle vie biliari 155
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 154
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 151
Liver metastases from carcinoid tumor: Imaging patterns 151
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 145
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 144
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 143
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 142
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 138
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 137
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 137
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 121
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 117
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 115
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 111
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 110
Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement 109
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 105
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 100
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 99
Totale 25.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.882
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.473 0 0 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20254.140 134 54 61 279 750 581 343 211 353 205 543 626
2025/20269.738 484 339 643 781 1.062 597 1.140 346 2.548 775 567 456
2026/2027812 252 519 41 0 0 0 0 0 0 0 0 0
Totale 25.525